The healthcare (AI) market is to exceed $10 billion by 2024, according to a new report. There will be significant drivers for growth in healthcare AI in the future – such as precision medicine and the need to reduce healthcare costs overall. Data-heavy technology such as genomics research, along with incremental innovation in robotic personal digital assistants could also boost growth according to the report. AI-based medical imaging and diagnosis will see more than 40% growth to more than $2.5 billion by 2024, the report predicted. U.S. healthcare artificial intelligence market was valued over USD 320 million in 2016 and is estimated to witness more than 38% CAGR over the coming years. Drug discovery applications account for over 35% of healthcare artificial intelligence market share, which could see the segment exceed $4 billion in revenue by 2024. Key clinical health AI and machine learning applications can potentially create $150 billion in annual savings for the U.S. healthcare economy by 2026. Revenue in the AI health market is expected to reach $6.6 billion by 2021

The global IoT healthcare market is expected to grow from USD32.4 Bn in 2015 to USD163.2 Bn by 2020, a CAGR of 38.1%. One of the world’s biggest markets for healthcare services, the United States spends approximately 18% of its GDP on healthcare every year. By improving adherence to prescribed therapies alone, the US could significantly reduce their healthcare spends. The effective deployment of IoT-based healthcare delivery technologies could help the US save well over USD 300 billion

Our 2nd Annual Pharma AI & IoT 2019 will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of techonologyy impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies,  our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. This event will provide an important platform for stakeholders to discuss and share best practices in furthering technology development in pharma and healthcare

It gives me great pleasure in welcoming all of you to the Virtue Insight’s 2nd Annual Pharma AI & IoT 2019.